1. Home
  2. MNPR vs SAR Comparison

MNPR vs SAR Comparison

Compare MNPR & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$59.35

Market Cap

368.9M

Sector

Health Care

ML Signal

HOLD

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

HOLD

Current Price

$22.40

Market Cap

361.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNPR
SAR
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
368.9M
361.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MNPR
SAR
Price
$59.35
$22.40
Analyst Decision
Strong Buy
Hold
Analyst Count
11
4
Target Price
$107.00
$23.75
AVG Volume (30 Days)
149.2K
81.3K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
14.34%
EPS Growth
54.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.39
P/E Ratio
N/A
$9.44
Revenue Growth
N/A
N/A
52 Week Low
$29.18
$20.78
52 Week High
$105.00
$25.64

Technical Indicators

Market Signals
Indicator
MNPR
SAR
Relative Strength Index (RSI) 47.52 50.29
Support Level $56.02 $22.24
Resistance Level $60.67 $22.84
Average True Range (ATR) 3.50 0.35
MACD -0.56 0.00
Stochastic Oscillator 15.69 45.56

Price Performance

Historical Comparison
MNPR
SAR

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: